High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology

Reviews of Infectious Diseases
J E Patterson, M J Zervos

Abstract

Antibiotic resistance is an ever-increasing problem in enterococci. These bacteria are remarkable in their ability to acquire and disseminate antibiotic resistance genes by a variety of routes. Since first described in 1979, high-level resistance to gentamicin (MIC, greater than 2,000 micrograms/mL) has spread worldwide and has been responsible for serious infections. Resistance is plasmid-mediated and due to aminoglycoside-modifying enzymes. High-level gentamicin resistance indicates that there will be no synergistic bactericidal activity with penicillin-gentamicin combinations. The epidemiology of nosocomial enterococcal infections is remarkably similar to that of nosocomial infections caused by methicillin-resistant staphylococci and by multidrug-resistant gram-negative bacilli. The most likely way these resistant bacteria are spread among hospital patients is via transient carriage on the hands of hospital personnel. Patient-to-patient and interhospital transmission of strains has been reported recently. However, clonal dissemination is not the cause of the increased frequency of resistant strains, since gentamicin resistance appears in a variety of different conjugative and nonconjugative plasmids in Enterococcus.

Citations

Jul 1, 1997·Indian Journal of Pediatrics·K G BhatM G Bhat
Nov 17, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S J McBrideS A Roberts
Nov 30, 2000·Current Infectious Disease Reports·K S Kaye, D Kaye
Jun 12, 2013·Current Infectious Disease Reports·Katherine Reyes, Marcus Zervos
Jul 10, 1993·Lancet·T R FriedenB Kreiswirth
Aug 1, 1993·Diagnostic Microbiology and Infectious Disease·M B PerriM J Zervos
Jan 1, 1993·Diagnostic Microbiology and Infectious Disease·P R MurrayC M Hampton
Aug 1, 1994·International Journal of Antimicrobial Agents· Shan-Chwen Chang Kwen-Tay Luh
May 17, 2005·The Journal of Hospital Infection·J Rodríguez-BañoL Martínez-Martínez
Oct 1, 1995·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·A Kaufhold, R Klein
Aug 1, 1993·The Journal of Applied Bacteriology·M Aguirre, M D Collins
Jul 1, 1997·Equine Veterinary Journal·J A Orsini, P Spencer
Nov 1, 1992·Antimicrobial Agents and Chemotherapy·D R SchabergC A Kauffman
Dec 1, 1993·Antimicrobial Agents and Chemotherapy·A Kaufhold, E Potgieter
May 1, 1994·Antimicrobial Agents and Chemotherapy·L A ThalM J Zervos
Sep 1, 1995·Antimicrobial Agents and Chemotherapy·L A ThalM J Zervos
Jul 19, 2006·Clinical Microbiology Reviews·Aparajita SinghMarcus J Zervos
Dec 25, 2012·International Journal of Environmental Research and Public Health·Vittoria CinquepalmiLeonardo Soleo
Apr 4, 2003·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Intetsu KobayashiAkihiro Kaneko
Feb 1, 1993·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·A Kaufhold, P Ferrieri
Jun 18, 2011·The Medical Clinics of North America·Luke F ChenKeith S Kaye
Nov 17, 2009·Infectious Disease Clinics of North America·Luke F ChenKeith S Kaye
May 1, 1992·The Journal of Hospital Infection·J W Gray, S J Pedler
Sep 1, 1994·The Journal of Pediatrics·C ChristieJ Evans-Patterson
Jun 1, 2000·Infectious Disease Clinics of North America·K S KayeE Abrutyn
Aug 17, 2004·Infectious Disease Clinics of North America·Keith S KayeElias Abrutyn
Jan 1, 1996·Annual Review of Medicine·G A Jacoby
Jun 1, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M Armstrong-EvansA McGeer
May 1, 1996·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L M DembryM J Zervos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.